Document Detail


Part I. Molecular and cellular characterization of high nitric oxide-adapted human breast adenocarcinoma cell lines.
MedLine Citation:
PMID:  23238815     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
There is a lack of understanding of the casual mechanisms behind the observation that some breast adenocarcinomas have identical morphology and comparatively different cellular growth behavior. This is exemplified by a differential response to radiation, chemotherapy, and other biological intervention therapies. Elevated concentrations of the free radical nitric oxide (NO), coupled with the up-regulated enzyme nitric oxide synthase (NOS) which produces NO, are activities which impact tumor growth. Previously, we adapted four human breast cancer cell lines: BT-20, Hs578T, T-47D, and MCF-7 to elevated concentrations of nitric oxide (or high NO [HNO]). This was accomplished by exposing the cell lines to increasing levels of an NO donor over time. Significantly, the HNO cell lines grew faster than did each respective ("PARENT") cell line even in the absence of NO donor-supplemented media. This was evident despite each "parent" being morphologically equivalent to the HNO adapted cell line. Herein, we characterize the HNO cells and their biological attributes against those of the parent cells. Pairs of HNO/parent cell lines were then analyzed using a number of key cellular activity criteria including: cell cycle distribution, DNA ploidy, response to DNA damage, UV radiation response, X-ray radiation response, and the expression of significant cellular enzymes. Other key enzyme activities studied were NOS, p53, and glutathione S-transferase-pi (GST-pi) expression. HNO cells were typified by a far more aggressive pattern of growth and resistance to various treatments than the corresponding parent cells. This was evidenced by a higher S-phase percentage, variable radioresistance, and up-regulated GST-pi and p53. Taken collectively, this data provides evidence that cancer cells subjected to HNO concentrations become resistant to free radicals such as NO via up-regulated cellular defense mechanisms, including p53 and GST-pi. The adaptation to NO may explain how tumor cells acquire a more aggressive tumor phenotype.
Authors:
B J Vesper; A Onul; G K Haines; G Tarjan; J Xue; K M Elseth; B Aydogan; M B Altman; J C Roeske; W A Paradise; H De Vitto; J A Radosevich
Related Documents :
23917535 - Contribution of membrane progesterone receptor α to the induction of progesterone-media...
24481275 - Analysis of microglial migration by a micropipette assay.
23167625 - Selective cox-2 inhibitor (celecoxib) decreases cellular growth in prostate cancer cell...
23376055 - Roles of p38 mapk and jnk in tgf-β1-induced human alveolar epithelial to mesenchymal tr...
17215065 - The delayed genotoxic effect of n-nitroso n-propoxur insecticide in mammalian cells.
2464605 - Increased epidermal growth factor receptor in multidrug-resistant human neuroblastoma c...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-12-14
Journal Detail:
Title:  Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine     Volume:  -     ISSN:  1423-0380     ISO Abbreviation:  Tumour Biol.     Publication Date:  2012 Dec 
Date Detail:
Created Date:  2012-12-14     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8409922     Medline TA:  Tumour Biol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Center for Molecular Biology of Oral Diseases, University of Illinois at Chicago, College of Dentistry, 801 S. Paulina Street, Chicago, IL, 60612, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Variable Phenotypes of Knockin Mice Carrying the M712T Gne Mutation.
Next Document:  Part II. Mitochondrial mutational status of high nitric oxide adapted cell line BT-20 (BT-20-HNO) as...